Clinical Trials in Romans-sur-Isère, France
10 recruiting
Showing 1–12 of 12 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)
Prurigo Nodularis
Incyte Corporation330 enrolled120 locationsNCT06516952
Recruiting
Phase 3
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
Hidradenitis Suppurativa (HS)
Incyte Corporation600 enrolled318 locationsNCT06855498
Recruiting
Evaluation by Confocal Reflectance Microscopy of the Skin Structure of Patients With Atopic Dermatitis Treated With Tralokinumab Biotherapy.
atopic dermatitis (eczema)Atopic Dermatitis (AD)
Hôpitaux Drôme Nord15 enrolled1 locationNCT07568665
Recruiting
Phase 3
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
Severe Alopecia Areata
Pfizer140 enrolled41 locationsNCT07029828
Recruiting
Phase 3
Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatment of Carcinomas Spinocellular With High Risk of Recurrence
Cutaneous Squamous Cell Carcinoma (CSCC)
Centre Leon Berard266 enrolled28 locationsNCT06692556
Recruiting
Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Plaque Psoriasis
AbbVie700 enrolled70 locationsNCT07039110
Recruiting
French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)
Atopic Dermatitis
Sanofi600 enrolled60 locationsNCT06837454
Recruiting
Phase 3
A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
Severe Alopecia Areata
Pfizer225 enrolled80 locationsNCT07029711
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis
Atopic Dermatitis
Incyte Corporation240 enrolled96 locationsNCT06832618
Recruiting
A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis.
Atopic DermatitisEczema
Pfizer183 enrolled30 locationsNCT05689151
Recruiting
Not Applicable
Low-Protein Diet With Low-Protein Foods Versus a LPD Without LP Foods in Patients With Chronic Kidney Disease (CKD)
Chronic Kidney Disease stage4Chronic Kidney Disease Stage 5Chronic Kidney Disease Stage 3B+1 more
Dr. Schär AG / SPA244 enrolled21 locationsNCT05489120
Recruiting
Phase 3
Randomised Study Evaluating Adjuvant Chemotherapy After Resection of Stage III Colonic Adenocarcinoma in Patients of 70 and Over
Colonic Adenocarcinoma
Federation Francophone de Cancerologie Digestive774 enrolled140 locationsNCT02355379